Sialorrhea and Hypersalivation Management

Clinical Distinctions and Implications

• Secondary sialorrhea, the most common form in clinical practice, is characterized by normal or reduced saliva production with impaired clearance, often resulting from poor oral and facial muscle control, dysphagia, or impaired swallowing, and is commonly seen in neurologically impaired patients with conditions such as cerebral palsy, Parkinson's disease, stroke, ALS, and other neuromuscular diseases 1, 2, 3, 4
• The American College of Chest Physicians guidelines recommend first-line therapy with oral anticholinergic agents, such as glycopyrrolate or sublingual atropine drops, regardless of whether the problem is primary or secondary, with the decision to continue anticholinergics based on whether benefits outweigh side effects 5, 6
• For refractory cases, escalation to anticholinergic patches, botulinum toxin injections, or radiation therapy may be considered, as recommended by the American College of Chest Physicians guidelines 5, 6
• Secondary sialorrhea increases the risk of aspiration pneumonia due to impaired airway protection, highlighting the importance of appropriate management 5